NYLIM
EW icon

New York Life Investment Management’s Edwards Lifesciences EW Stock Holding History

New York Life Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.78M Sell
85,965
-813
-0.9% -$68.1K 0.05% 271
2026
Q1 		$6.95M Buy
86,778
+2,473
+3% +$204K 0.06% 264
2025
Q4 		$7.19M Sell
84,305
-1,435
-2% -$118K 0.06% 253
2025
Q3 		$6.67M Sell
85,740
-4,171
-5% -$326K 0.06% 278
2025
Q2 		$7.03M Buy
89,911
+229
+0.3% +$17.1K 0.07% 254
2025
Q1 		$6.5M Sell
89,682
-1,151
-1% -$82.4K 0.07% 264
2024
Q4 		$6.72M Sell
90,833
-332
-0.4% -$23.2K 0.07% 257
2024
Q3 		$6.02M Sell
91,165
-2,677
-3% -$194K 0.06% 299
2024
Q2 		$8.67M Buy
93,842
+256
+0.3% +$22.7K 0.09% 215
2024
Q1 		$8.94M Sell
93,586
-3,145
-3% -$264K 0.09% 209
2023
Q4 		$7.38M Buy
96,731
+484
+0.5% +$33.7K 0.08% 229
2023
Q3 		$6.67M Buy
96,247
+467
+0.5% +$37.5K 0.07% 253
2023
Q2 		$9.03M Sell
95,780
-1,846
-2% -$160K 0.09% 203
2023
Q1 		$8.08M Buy
97,626
+113
+0.1% +$8.88K 0.09% 228
2022
Q4 		$7.28M Sell
97,513
-494
-0.5% -$38.1K 0.08% 244
2022
Q3 		$8.1M Sell
98,007
-444
-0.5% -$42.7K 0.1% 217
2022
Q2 		$9.36M Buy
+98,451
New +$10.2M 0.11% 197

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

New York Life Investment Management's EW Position: Q2 2026 in Review

New York Life Investment Management reduced its Edwards Lifesciences (EW) stake by 0.94% in Q2 2026, selling an estimated $68.1K and leaving 85,965 shares worth $7.78M. The position accounts for 0.05% of the portfolio, ranked #271.

New York Life Investment Management first reported a position in EW in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.36M in Q2 2022. 1,001 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • New York Life Investment Management held 85,965 shares of Edwards Lifesciences worth $7.78M as of Q2 2026.
  • New York Life Investment Management sold 813 Edwards Lifesciences shares in Q2 2026, an estimated $68.1K.
  • Edwards Lifesciences made up 0.05% of New York Life Investment Management's portfolio in Q2 2026, its #271 holding.
  • New York Life Investment Management first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Edwards Lifesciences position peaked at $9.36M in Q2 2022.
  • 1,001 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.